|
US4235877A
(en)
|
1979-06-27 |
1980-11-25 |
Merck & Co., Inc. |
Liposome particle containing viral or bacterial antigenic subunit
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
AU614755B2
(en)
|
1987-06-05 |
1991-09-12 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Autocrine motility factors in cancer diagnosis and management
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
DE3734306A1
(de)
|
1987-10-10 |
1989-04-27 |
Pfeiffer Erich Gmbh & Co Kg |
Austragvorrichtung fuer fliessfaehige medien
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
HUT58804A
(en)
|
1988-12-16 |
1992-03-30 |
James Cleland Paton |
Process for producing pneumolysine mutants and pneumococcus vaccines
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
DE4005528C2
(de)
|
1990-02-22 |
1998-01-15 |
Pfeiffer Erich Gmbh & Co Kg |
Austragvorrichtung für Medien
|
|
US6592876B1
(en)
|
1993-04-20 |
2003-07-15 |
Uab Research Foundation |
Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
|
|
US5476929A
(en)
|
1991-02-15 |
1995-12-19 |
Uab Research Foundation |
Structural gene of pneumococcal protein
|
|
JP3215109B2
(ja)
|
1991-02-15 |
2001-10-02 |
ユーエイビー リサーチ ファウンデーション |
肺炎球菌タンパクの構造遺伝子
|
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
ES2162139T5
(es)
|
1993-03-23 |
2008-05-16 |
Smithkline Beecham Biologicals S.A. |
Composiciones de vacuna que contienen monofosforil-lipido a 3-o-desacilado.
|
|
CN1055093C
(zh)
|
1993-11-17 |
2000-08-02 |
实验室奥姆公司 |
葡糖胺二糖类、其制备方法和用途、以及含有这些二糖的药物组合物
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
ATE323721T1
(de)
|
1996-05-01 |
2006-05-15 |
Univ Rockefeller |
Cholin-bindendes protein, welches als gegen pneumokokken gerichtetes vakzin verwendet wird
|
|
DE69719761T2
(de)
|
1996-06-18 |
2003-12-18 |
Alza Corp., Palo Alto |
Vorrichtung zur verbesserung der transdermalen verabreichung von medikamenten oder der abnahme von körperflüssigkeiten
|
|
JP2000514308A
(ja)
|
1996-08-16 |
2000-10-31 |
スミスクライン・ビーチャム・コーポレイション |
新規原核生物ポリヌクレオチド、ポリペプチドおよびそれらの使用
|
|
WO1998018931A2
(en)
|
1996-10-31 |
1998-05-07 |
Human Genome Sciences, Inc. |
Streptococcus pneumoniae polynucleotides and sequences
|
|
CA2269636A1
(en)
|
1996-11-12 |
1998-05-22 |
The Regents Of The University Of Minnesota |
C3 binding protein of streptococcus pneumoniae
|
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
DK0957972T3
(da)
|
1996-12-20 |
2003-07-21 |
Alza Corp |
Anordning og fremgangsmåde til at forøge transdermal middelflux
|
|
DE19708537A1
(de)
|
1997-03-03 |
1998-09-10 |
Biotechnolog Forschung Gmbh |
Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc.
|
|
US6764840B2
(en)
|
1997-05-08 |
2004-07-20 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US6303347B1
(en)
|
1997-05-08 |
2001-10-16 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
US6800744B1
(en)
|
1997-07-02 |
2004-10-05 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
|
|
JP2001510031A
(ja)
*
|
1997-07-21 |
2001-07-31 |
ノース・アメリカン・ヴァクシン・インコーポレーテッド |
ワクチンとしての修飾された免疫原ニューモリシン組成物
|
|
JP2001517449A
(ja)
|
1997-09-24 |
2001-10-09 |
リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミネソタ |
ストレプトコッカス・ニューモニア由来のヒト補体ｃ３分解プロテイナーゼ
|
|
EP1035867A1
(en)
|
1997-12-02 |
2000-09-20 |
Powderject Vaccines, Inc. |
Transdermal delivery of particulate vaccine compositions
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
MXPA00009899A
(es)
|
1998-04-07 |
2002-05-08 |
St Jude Childrens Res Hospital |
Polipeptido que comprende la secuencia de aminoacidos de un truncado n- terminal de proteina a de union a colina, vacuna derivada del mismo y usos del los mismos.
|
|
ES2343492T3
(es)
|
1998-04-07 |
2010-08-02 |
Medimmune, Llc |
Derivados de proteinas neumococicas de union a colina para vacunas.
|
|
EP1073450A4
(en)
|
1998-04-23 |
2003-04-23 |
Uab Research Foundation |
PNEUMOCOCCAL SURFACE PROTEIN C (PSPC), EPITOPIC REGIONS, SELECTION OF CORRESPONDING STRES AND USES
|
|
SK18602000A3
(sk)
|
1998-06-08 |
2001-07-10 |
Sca Emballage France |
Obal umožňujúci rýchle vyrovnanie
|
|
CZ302062B6
(cs)
|
1998-06-30 |
2010-09-22 |
Om Pharma |
Derivát acyldipeptidu, zpusob jeho prípravy, meziprodukty pro jeho prípravu a farmaceutický prostredek, který ho obsahuje
|
|
EP1115875A1
(en)
|
1998-09-24 |
2001-07-18 |
Regents Of The University Of Minnesota |
Human complement c3-degrading polypeptide from streptococcus pneumoniae
|
|
WO2000030299A1
(en)
|
1998-11-17 |
2000-05-25 |
Schlumberger Technology Corporation |
Transmitting information over a communication link
|
|
WO2000029434A2
(en)
|
1998-11-19 |
2000-05-25 |
St. Jude Children's Research Hospital |
PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF
|
|
DK1140157T3
(da)
*
|
1998-12-21 |
2009-06-08 |
Medimmune Inc |
Streptococcus pneumoniae-proteiner og immunogene fragmenter til vacciner
|
|
ATE394489T1
(de)
|
1998-12-23 |
2008-05-15 |
Id Biomedical Corp |
Streptococcus antigene
|
|
TR200103018T2
(tr)
|
1999-04-19 |
2002-02-21 |
Beecham Biologicals S.A. Smithkline |
İmmünostimülatör oligonükleotid ve saponin içeren katkı bileşikleri.
|
|
ES2264419T3
(es)
|
1999-06-10 |
2007-01-01 |
Medimmune, Inc. |
Vacunas y proteinas de streptococcus pneumoniae.
|
|
FR2796291B1
(fr)
|
1999-07-16 |
2001-09-21 |
Cross Site Technologies |
Seringue sans aiguille munie d'un systeme de declenchement piezo-electrique
|
|
FR2796290B1
(fr)
|
1999-07-16 |
2001-09-14 |
Cross Site Technologies |
Seringue sans aiguille fonctionnant avec un generateur d'onde de choc a travers une paroi
|
|
FR2796289B1
(fr)
|
1999-07-16 |
2001-08-10 |
Cross Site Technologies |
Seringue sans aiguille avec injecteur a elements superposes
|
|
US6319224B1
(en)
|
1999-08-20 |
2001-11-20 |
Bioject Medical Technologies Inc. |
Intradermal injection system for injecting DNA-based injectables into humans
|
|
US6494865B1
(en)
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
|
FR2800619B1
(fr)
|
1999-11-05 |
2002-02-08 |
Cross Site Technologies |
Seringue sans aiguille avec un moyen de poussee temporairement retenu
|
|
FR2802102B1
(fr)
|
1999-12-08 |
2002-07-12 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille munie d'un tube d'ejection a section constante
|
|
FR2802103B1
(fr)
|
1999-12-08 |
2003-10-03 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille fonctionnant avec entrainement du principe actif par effet tube a choc
|
|
AU1581400A
(en)
|
1999-12-22 |
2001-07-03 |
Om Pharma |
Acyl pseudopeptides bearing a functionalised auxiliary spacer
|
|
FR2802820B1
(fr)
|
1999-12-27 |
2002-10-18 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille fonctionnant par effet tube a choc, avec maintien prealable du principe actif sur le cote
|
|
FR2804329B1
(fr)
|
2000-02-02 |
2002-12-13 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille munie d'un opercule contenant le principe actif
|
|
FR2804869B1
(fr)
|
2000-02-11 |
2002-05-17 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille pour l'injection d'un liquide contenu dans une ampoule pre-remplie
|
|
FR2805749B1
(fr)
|
2000-03-01 |
2002-05-17 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille a deux niveaux de vitesse d'injection
|
|
FR2807946B1
(fr)
|
2000-04-19 |
2002-06-07 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille fonctionnant avec un chargement pyrotechnique bicomposition
|
|
FR2809626B1
(fr)
|
2000-05-30 |
2003-03-07 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille avec membrane d'isolation d'un ejecteur multiconduit
|
|
EA006232B1
(ru)
|
2000-06-20 |
2005-10-27 |
Ай Ди Биомедикал Корпорейшн |
Стрептококковые антигены
|
|
FR2810554B1
(fr)
|
2000-06-22 |
2003-05-16 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille munie d'un reservoir modulable
|
|
FR2812202B1
(fr)
|
2000-07-28 |
2002-09-13 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille fonctionnant par mise en compression du reservoir contenant le principe actif liquide
|
|
GB0022742D0
(en)
*
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
|
FR2815544B1
(fr)
|
2000-10-23 |
2003-02-14 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille securisee a architecture compacte
|
|
US20030031684A1
(en)
|
2001-03-30 |
2003-02-13 |
Corixa Corporation |
Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid a (3D-MLA)
|
|
US7217791B2
(en)
|
2002-11-07 |
2007-05-15 |
Synergy America, Inc. |
Compositions and methods for treating or preventing pneumococcal infection
|
|
DE602004010376T2
(de)
*
|
2003-03-13 |
2008-10-23 |
Glaxosmithkline Biologicals S.A. |
Verfahren zur reinigung von bakteriellem cytolysin
|
|
WO2005076696A2
(en)
|
2004-02-13 |
2005-08-25 |
Sanofi Pasteur Limited |
Pneumolysin derivatives
|
|
GB0410220D0
(en)
|
2004-05-07 |
2004-06-09 |
Kirkham Lea Ann |
Mutant pneumolysin proteins
|
|
GB0421083D0
(en)
|
2004-09-22 |
2004-10-27 |
Glaxosmithkline Biolog Sa |
Purification process
|
|
TWI457133B
(zh)
*
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
GB0525321D0
(en)
*
|
2005-12-13 |
2006-01-18 |
Glaxosmithkline Biolog Sa |
Novel compositions
|
|
PL3017827T3
(pl)
|
2005-12-22 |
2019-04-30 |
Glaxosmithkline Biologicals Sa |
Szczepionka z koniugatem polisacharydu pneumokokowego
|
|
US8273361B2
(en)
*
|
2006-09-26 |
2012-09-25 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
AU2008280799B2
(en)
|
2007-07-23 |
2013-07-11 |
Sanofi Pasteur Limited |
Immunogenic polypeptides and monoclonal antibodies
|
|
AU2008280755B9
(en)
|
2007-07-26 |
2014-09-25 |
Sanofi Pasteur Limited |
Antigen-adjuvant compositions and methods
|
|
GB0724357D0
(en)
|
2007-12-14 |
2008-01-23 |
Glaxosmithkline Biolog Sa |
Method for preparing protein conjugates
|
|
ES2331863B1
(es)
|
2008-07-15 |
2010-10-27 |
Consejo Superior De Investigaciones Cientificas (Csic) |
Bacterias y productos derivados para fortalecer las defensas y reducir el riesgo de enfermedad.
|
|
BRPI0923649A2
(pt)
*
|
2008-12-24 |
2016-01-19 |
Netherlands Vaccine Inst |
polipeptídeos de pneumolisina (ply) de streptococcus pneumoniae modificados.
|
|
NZ595223A
(en)
|
2009-03-24 |
2013-12-20 |
Novartis Ag |
Combinations including pneumococcal serotype 14 saccharide
|
|
ES2531115T3
(es)
|
2009-06-01 |
2015-03-10 |
Novartis Ag |
Combinaciones de clados de RrgB neumocócicos
|
|
US20130183350A1
(en)
|
2009-12-22 |
2013-07-18 |
Kevin Harper |
Immunogenic compositions
|